Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.130
-0.010 (-0.88%)
At close: Oct 31, 2025, 4:00 PM EDT
1.090
-0.040 (-3.54%)
After-hours: Oct 31, 2025, 8:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $23.44 million as of October 31, 2025. Its market cap has increased by 17.76% in one year.
Market Cap
23.44M
Enterprise Value
20.41M
1-Year Change
17.76%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $23.44M, a decrease of -29.80%. That is a compound annual growth rate of -27.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 23.65M | 21.10% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.15B |
| Johnson & Johnson | 446.42B |
| AbbVie | 398.22B |
| UnitedHealth Group | 325.09B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 217.19B |